Low Back PainAPPROCHENCT07051772
Predictive Factors for the Success of Rehabilitation Programs in Chronic Low Back Pain
An observational study of Low Back Pain, run by Centre Hospitalier Universitaire de Nīmes at 6 sites in France.
Trial summary
Chronic low back pain is the leading cause of years lived with disability in the world among 19-49 year olds. The usual progression leads to 15% of acute episodes of persistent pain and more than 50% of persistent activity limitations. Read more about this study
- Who is it for?
- Ages 18 to 65 years
- Conditions the study is for
- Low Back Pain
- What is being tested?
- mobility skills testing session
- How many people
- 333 participants
- Where
- 6 sitesFrance
- Study dates
- 19 Feb 2025to Aug 2028
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 65 years
- All sexes
- Adult, Older adult
Study population: The study population consists of patients from the active consultation line in the Physical Medicine and Rehabilitation departments of the University Hospitals of Nîmes, Montpellier and Clermont-Ferrand for chronic low back pain.
Who may be able to join
- Patient with chronic low back pain ≥ three months
- The patient must have given their free and informed consent and signed the consent form
- The patient must be a member or beneficiary of a health insurance plan
Who cannot join
- The patient is participating in a category 1 interventional study, or a study on a medication or medical device without prior approval of the primary investigator
- The patient is in a period of exclusion determined by a previous study
- It is impossible to give the subject informed information
- The patient is under safeguard of justice or state guardianship
- Patient followed or treated for a psychiatric, cancerous or orthopedic pathology that risks modifying their course of care
- Pregnant, parturient or breastfeeding patient.
Trial locations and contacts
6 sites in 1 country. Contact the study team or a site near you to ask about taking part.
6 sites in 1 country
France6 sites, 6 recruiting
- Not yet recruiting
CHU de Clermont Ferrand
Clermont-Ferrand, Auvergne, 63000
Emmanuel COUDEYRE, Pr., +33 4.73.75.09.00, ecoudeyre@chu-clermontferrand.fr
- Not yet recruiting
CHU de Clermont-Ferrand
Clermont-Ferrand
Emmanuel Coudeyre, 04.73.75.09.00, ecoudeyre@chu-clermontferrand.fr
- Not yet recruiting
CHU de Montpellier
Montpellier, Occitanie, 34000
Isabelle TAVARES, Pr., +33 4.67.33.87.17, i-tavaresfigueiredo@chu-montpellier.fr
- Not yet recruiting
CHU de Montpellier
Montpellier
Isabelle Tavares, 04.67.33.87.17, i-tavaresfigueiredo@chu-montpellier.fr
- Not yet recruiting
Centre Hospitalier Universitaire de Nîmes
Nîmes, Gard, 30900
Anissa Megzari, Prof., 04.66.68.42.62, drc@chu-nimes.fr
Arnaud Dupeyron
- Recruiting
CHU de Nîmes
Nîmes, Occitanie, 30029
Arnaud DUPEYRON, Pr., +33 4.66.68.34.59, arnaud.dupeyron@umontpellier.fr
About this study
Chronic low back pain is the leading cause of years lived with disability in the world among 19-49 year olds. The usual progression leads to 15% of acute episodes of persistent pain and more than 50% of persistent activity limitations. Persistent pain lasting between 5 and 7 years causes relatively stable patterns, probably linked to well-known predictive factors of activity limitations such as psychosocial factors (catastrophizing, fears and maladaptive beliefs), physical (deconditioning), professional (fear of returning to work, stress, burden) or personal (financial, insecurity). The effectiveness of treatments is often difficult to predict. Current evidence does not support the use of pharmacological treatments given their low effectiveness and the risks associated with the prescription of non-steroidal anti-inflammatories or opioids, particularly in the chronic phase where the risk of dependence is highest. Thus, international recommendations strongly suggest the use of non-pharmacological therapies, including, physical exercises, rehabilitation, physical and sports activities and spinal manipulations. Most meta-analyses conclude that there is a cumulative effect of the different strategies, without the specific effect of each one being able to be isolated, justifying multidisciplinary protocols. A cornerstone of the management of chronic disabling low back pain therefore relies programs combining physical, cognitive-behavioral, psychological and professional care, most often in dedicated centers. The objective is to empower the patient and promote a change in behavior with regard to the consequences of their pain in the long-term. However, there are very few predictive criteria for the success or failure of these programs, probably because many multiple biological, psychological, and social factors interact over time. Certain models resulting from expert consensus seek to conceptualize these interactions and propose a categorization of these different factors. It is now crucial to validate these categorizations and their relative weight in the progression of patients to best guide their recovery. The aim of this work is to identify the biomarkers predictive of the success of multidisciplinary programs in the short-, medium- and long-term.
- Conditions
- Low Back Pain
- Being tested
- mobility skills testing session
- Keywords
- Biomarkers
- Medical subject headings
- Low Back Pain
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
mobility skills testing sessionOther
A mobility skills testing session using the Qualisys system (Trinoma), when carrying out specific tasks plus 7-day recording of activity using an accelerometer.
| Study group | Role | What they receive |
|---|---|---|
| Patients recruited from Nîmes center | Not described Receives: Other: mobility skills testing session |
What is being measured
The primary outcome is the main question the study is designed to answer.
Level of disability
Oswestry Disability Index questionnaire. Scoring: 0% to 20%: minimal disability, 20% to 40%: moderate disability, 40% to 60%: severe disability, 60% to 80%: major disability, and 80% to 100 %: bedridden or exaggerated.
Measured: Baseline
Level of disability
Oswestry Disability Index questionnaire. Scoring: 0% to 20%: minimal disability, 20% to 40%: moderate disability, 40% to 60%: severe disability, 60% to 80%: major disability, and 80% to 100 %: bedridden or exaggerated.
Measured: Month 6
Patient age
Years
Measured: Baseline
Patient sex
Male/female
Measured: Baseline
Patient Body Mass Index
Kg/m2
Measured: Baseline
Comorbidities
List of medical pathologies and history of other pathologies of the musculoskeletal system (peripheral osteoarthritis, trauma to the musculoskeletal system, other musculoskeletal disorders).
Measured: Baseline
Pain duration
Months
Measured: Baseline
Professional situation
Description of profession
Measured: Baseline
Work stoppage
Yes/No
Measured: Baseline
Work accident
Yes/No
Measured: Baseline
Disability
Yes/No
Measured: Baseline
Professional Life Satisfaction Scale Socio-economic level
Measured: Baseline
Marital status
Measured: Baseline
Number of children
Number
Measured: Baseline
Kinesiophobia
Tampa scale
Measured: Baseline
Coping strategies
Coping Strategies Questionnaire
Measured: Baseline
Avoidance Beliefs
Fear-Avoidance Beliefs Questionnaire
Measured: Baseline
Self-efficacy
Pain Self-Efficacy Questionnaire
Measured: Baseline
Catastrophism
Pain Catastrophizing Scale
Measured: Baseline
Acceptance
Acceptance and Action Questionnaire
Measured: Baseline
Anxiety and depression
Hospital Anxiety and Depression Scale
Measured: Baseline
Mobility
Schöber test Finger-to-ground distance
Measured: Baseline
Static endurance of the abdominal muscles
Shirado test, seconds
Measured: Baseline
Isometric endurance of hip and back extensor muscles
Sorensen test, seconds
Measured: Baseline
Central Sensitization
Central Sensitization Inventory
Measured: Baseline
Location of pain
Patient-described using a body diagram
Measured: Baseline
Number and severity of discopathies
Pfirmann classification, measured on MRI
Measured: Baseline
Modic changes on MRI
Present/Absent
Measured: Baseline
Narrow lumbar canal
Yes/No, Measured on MRI
Measured: Baseline
Postural disorder
Yes/No
Measured: Baseline
Scoliosis
Cobb angle
Measured: Baseline
Sagittal balance
Measured using weight-bearing x-rays
Measured: Baseline
Physical Activity
International Physical Activity Questionnaire
Measured: Baseline
Exercise Adherence Rating Scale Sleep
Pittsburgh Questionnaire
Measured: Baseline
Smoking
Measured: Baseline
Alcohol consumption
Measured: Baseline
Drug use
Yes/No
Measured: Baseline
Knowledge about low back pain
Back Beliefs Questionnaire
Measured: Baseline
Treatment pathway
Description of previous physiotherapy treatments, infiltrations, osteopathy/manual therapy, medicinal treatments
Measured: Baseline
Secondary outcomes (45)
Level of disability
Oswestry Disability Index questionnaire. Scoring: 0% to 20%: minimal disability, 20% to 40%: moderate disability, 40% to 60%: severe disability, 60% to 80%: major disability, and 80% to 100 %: bedridden or exaggerated.
Measured: Month 1
Level of disability
Oswestry Disability Index questionnaire. Scoring: 0% to 20%: minimal disability, 20% to 40%: moderate disability, 40% to 60%: severe disability, 60% to 80%: major disability, and 80% to 100 %: bedridden or exaggerated.
Measured: Month 3
Level of disability
Oswestry Disability Index questionnaire. Scoring: 0% to 20%: minimal disability, 20% to 40%: moderate disability, 40% to 60%: severe disability, 60% to 80%: major disability, and 80% to 100 %: bedridden or exaggerated.
Measured: Month 12
Level of pain
Visual Analog Scale, 0-100
Measured: Month 1
Level of pain
Visual Analog Scale, 0-100
Measured: Month 3
Level of pain
Visual Analog Scale, 0-100
Measured: Month 6
Level of pain
Visual Analog Scale, 0-100
Measured: Month 12
Patient-reported health-related quality of life
Quality of life questionnaire EQ-5D questionnaire, score 0-100
Measured: Baseline
Patient-reported health-related quality of life
EQ-5D questionnaire, score 0-100
Measured: Month 1
Patient-reported health-related quality of life
Quality of life questionnaire EQ-5D questionnaire, score 0-100
Measured: Month 3
Patient-reported health-related quality of life
EQ-5D questionnaire, score 0-100
Measured: Month 6
Patient-reported health-related quality of life
EQ-5D questionnaire, score 0-100
Measured: Month 12
Return to work
Number of days until return to work after end of physiotherapy program
Measured: Month 12
Patients' feelings about symptoms
PGI-C (Patient Global Impression of Change) questionnaire, score 1-7
Measured: Month 1
Patients' feelings about symptoms
PGI-C (Patient Global Impression of Change) questionnaire, score 1-7
Measured: Month 3
Patients' feelings about symptoms
PGI-C (Patient Global Impression of Change) questionnaire, score 1-7
Measured: Month 6
Patients' feelings about symptoms
PGI-C (Patient Global Impression of Change) questionnaire, score 1-7
Measured: Month 12
Mobility abilities of willing patients recruited in the Nîmes center during walking
Three-dimensional optokinetic analysis using Qualisys system
Measured: Baseline
Mobility abilities of willing patients recruited in the Nîmes center during trunk lateral rotations
Three-dimensional optokinetic analysis using Qualisys system
Measured: Baseline
Mobility abilities of willing patients recruited in the Nîmes center during drop jumps
Three-dimensional optokinetic analysis using Qualisys system
Measured: Baseline
Mobility abilities of willing patients recruited in the Nîmes center during Star Excursion Balance Test
Three-dimensional optokinetic analysis using Qualisys system
Measured: Baseline
Mobility abilities of willing patients recruited in the Nîmes center during walking
Three-dimensional optokinetic analysis using Qualisys system
Measured: Month 3
Mobility abilities of willing patients recruited in the Nîmes center during trunk lateral rotations
Three-dimensional optokinetic analysis using Qualisys system
Measured: Month 3
Mobility abilities of willing patients recruited in the Nîmes center during drop jumps
Three-dimensional optokinetic analysis using Qualisys system
Measured: Month 3
Mobility abilities of willing patients recruited in the Nîmes center during Star Excursion Balance Test
Three-dimensional optokinetic analysis using Qualisys system
Measured: Month 3
Moderate-to-vigorous physical activity level of willing patients recruited in the Nîmes center over 7 days
Measured using an accelerometer (ActiGraph, GTX3), minutes
Measured: Baseline
Moderate-to-vigorous physical activity level of willing patients recruited in the Nîmes center over 7 days
Measured using an accelerometer (ActiGraph, GTX3), minutes
Measured: Month 3
Accelerometric parameters of willing patients recruited in the Nîmes center of walking over 7 days
Periods of walking >10 seconds
Measured: Baseline
Accelerometric parameters of willing patients recruited in the Nîmes center of walking over 7 days
Periods of walking >10 seconds
Measured: Month 3
Number of steps of willing patients recruited in the Nîmes center over 7 days
Number, measured using an accelerometer (ActiGraph, GTX3)
Measured: Baseline
Number of steps of willing patients recruited in the Nîmes center over 7 days
Number, measured using an accelerometer (ActiGraph, GTX3)
Measured: Month 3
Duration of a walking period of willing patients recruited in the Nîmes center over 7 days
Minutes, measured using an accelerometer (ActiGraph, GTX3)
Measured: Baseline
Duration of a walking period of willing patients recruited in the Nîmes center over 7 days
Minutes, measured using an accelerometer (ActiGraph, GTX3)
Measured: Month 3
Walking speed of willing patients recruited in the Nîmes center
Km/hour
Measured: Baseline
Walking speed of willing patients recruited in the Nîmes center
Km/hour
Measured: Month 3
Length of strides of willing patients recruited in the Nîmes center
Measured using an accelerometer (ActiGraph, GTX3)
Measured: Baseline
Length of strides of willing patients recruited in the Nîmes center
Measured using an accelerometer (ActiGraph, GTX3)
Measured: Month 3
Duration of strides of willing patients recruited in the Nîmes center
Measured using an accelerometer (ActiGraph, GTX3)
Measured: Baseline
Duration of strides of willing patients recruited in the Nîmes center
Measured using an accelerometer (ActiGraph, GTX3)
Measured: Month 3
Frequency of strides
Medio-lateral and antero-posterior, measured using an accelerometer (ActiGraph, GTX3)
Measured: Baseline
Frequency of strides
Medio-lateral and antero-posterior, measured using an accelerometer (ActiGraph, GTX3)
Measured: Month 3
Acceleration of willing patients recruited in the Nîmes center
Root mean square of the variability of the amplitude of acceleration, measured using an accelerometer (ActiGraph, GTX3)
Measured: Baseline
Acceleration of willing patients recruited in the Nîmes center
Root mean square of the variability of the amplitude of acceleration, measured using an accelerometer (ActiGraph, GTX3)
Measured: Month 3
Gait regularity of willing patients recruited in the Nîmes center
measured using an accelerometer (ActiGraph, GTX3)
Measured: Baseline
Gait regularity of willing patients recruited in the Nîmes center
measured using an accelerometer (ActiGraph, GTX3)
Measured: Month 3
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted4 Jul 2025
- Study start19 Feb 2025
- Primary completionFeb 2028 (estimated)
- Study completionAug 2028 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Low Back PainStudies of the same condition, open and under way.
- More trials run by Centre Hospitalier Universitaire de NīmesThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 333 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Centre Hospitalier Universitaire de Nīmes
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Arnaud Dupeyron, Principal investigator, CHU de Nimes
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07051772
- Sponsor's protocol ID
- NIMAO/2023-1/AD-01
- Acronym
- APPROCHE
- Status last verified
- Jan 2026
- First submitted
- 6 Mar 2025
- Last updated
- 16 Jan 2026
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 16 Jan 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Predictive Factors for the Success of Rehabilitation Programs in Chronic Low Back Pain
- ClinicalTrials.gov ID
- NCT07051772
- Acronym / sponsor ID
- APPROCHE / NIMAO/2023-1/AD-01
- Conditions
- Low Back Pain
- Keywords
- Biomarkers
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 333 participants (estimated)
- Lead sponsor
- Centre Hospitalier Universitaire de NīmesUniversity, hospital or other
- Study start
- 19 Feb 2025 (actual)
- Primary completion
- Feb 2028 (estimated)
- Study completion
- Aug 2028 (estimated)
- First posted
- 4 Jul 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Chronic low back pain is the leading cause of years lived with disability in the world among 19-49 year olds. The usual progression leads to 15% of acute episodes of persistent pain and more than 50% of persistent activity limitations. Persistent pain lasting between 5 and 7 years causes relatively stable patterns, probably linked to well-known predictive factors of activity limitations such as psychosocial factors (catastrophizing, fears and maladaptive beliefs), physical (deconditioning), professional (fear of returning to work, stress, burden) or personal (financial, insecurity). The effectiveness of treatments is often difficult to predict. Current evidence does not support the use of pharmacological treatments given their low effectiveness and the risks associated with the prescription of non-steroidal anti-inflammatories or opioids, particularly in the chronic phase where the risk of dependence is highest. Thus, international recommendations strongly suggest the use of non-pharmacological therapies, including, physical exercises, rehabilitation, physical and sports activities and spinal manipulations. Most meta-analyses conclude that there is a cumulative effect of the different strategies, without the specific effect of each one being able to be isolated, justifying multidisciplinary protocols. A cornerstone of the management of chronic disabling low back pain therefore relies programs combining physical, cognitive-behavioral, psychological and professional care, most often in dedicated centers. The objective is to empower the patient and promote a change in behavior with regard to the consequences of their pain in the long-term. However, there are very few predictive criteria for the success or failure of these programs, probably because many multiple biological, psychological, and social factors interact over time. Certain models resulting from expert consensus seek to conceptualize these interactions and propose a categorization of these different factors. It is now crucial to validate these categorizations and their relative weight in the progression of patients to best guide their recovery. The aim of this work is to identify the biomarkers predictive of the success of multidisciplinary programs in the short-, medium- and long-term.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Patients recruited from Nîmes center | – | Other: mobility skills testing session |
Who may qualify
- Ages
- 18 to 65 years
- Sex
- All
- Age groups
- Adult, Older adult
- Study population
- The study population consists of patients from the active consultation line in the Physical Medicine and Rehabilitation departments of the University Hospitals of Nîmes, Montpellier and Clermont-Ferrand for chronic low back pain.
Key inclusion criteria (3 listed)
- Patient with chronic low back pain ≥ three months
- The patient must have given their free and informed consent and signed the consent form
- The patient must be a member or beneficiary of a health insurance plan
Key exclusion criteria (6 listed)
- The patient is participating in a category 1 interventional study, or a study on a medication or medical device without prior approval of the primary investigator
- The patient is in a period of exclusion determined by a previous study
- It is impossible to give the subject informed information
- The patient is under safeguard of justice or state guardianship
- Patient followed or treated for a psychiatric, cancerous or orthopedic pathology that risks modifying their course of care
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| mobility skills testing sessionA mobility skills testing session using the Qualisys system (Trinoma), when carrying out specific tasks plus 7-day recording of activity using an accelerometer. | Other | Patients recruited from Nîmes center |
Primary outcome
Level of disability
Time frame: Baseline
Oswestry Disability Index questionnaire. Scoring: 0% to 20%: minimal disability, 20% to 40%: moderate disability, 40% to 60%: severe disability, 60% to 80%: major disability, and 80% to 100 %: bedridden or exaggerated.
Level of disability
Time frame: Month 6
Oswestry Disability Index questionnaire. Scoring: 0% to 20%: minimal disability, 20% to 40%: moderate disability, 40% to 60%: severe disability, 60% to 80%: major disability, and 80% to 100 %: bedridden or exaggerated.
Patient age
Time frame: Baseline
Years
Patient sex
Time frame: Baseline
Male/female
Patient Body Mass Index
Time frame: Baseline
Kg/m2
Comorbidities
Time frame: Baseline
List of medical pathologies and history of other pathologies of the musculoskeletal system (peripheral osteoarthritis, trauma to the musculoskeletal system, other musculoskeletal disorders).
Pain duration
Time frame: Baseline
Months
Professional situation
Time frame: Baseline
Description of profession
Work stoppage
Time frame: Baseline
Yes/No
Work accident
Time frame: Baseline
Yes/No
Disability
Time frame: Baseline
Yes/No
Professional Life Satisfaction Scale Socio-economic level
Time frame: Baseline
Marital status
Time frame: Baseline
Number of children
Time frame: Baseline
Number
Kinesiophobia
Time frame: Baseline
Tampa scale
Coping strategies
Time frame: Baseline
Coping Strategies Questionnaire
Avoidance Beliefs
Time frame: Baseline
Fear-Avoidance Beliefs Questionnaire
Self-efficacy
Time frame: Baseline
Pain Self-Efficacy Questionnaire
Catastrophism
Time frame: Baseline
Pain Catastrophizing Scale
Acceptance
Time frame: Baseline
Acceptance and Action Questionnaire
Anxiety and depression
Time frame: Baseline
Hospital Anxiety and Depression Scale
Mobility
Time frame: Baseline
Schöber test Finger-to-ground distance
Static endurance of the abdominal muscles
Time frame: Baseline
Shirado test, seconds
Isometric endurance of hip and back extensor muscles
Time frame: Baseline
Sorensen test, seconds
Central Sensitization
Time frame: Baseline
Central Sensitization Inventory
Location of pain
Time frame: Baseline
Patient-described using a body diagram
Number and severity of discopathies
Time frame: Baseline
Pfirmann classification, measured on MRI
Modic changes on MRI
Time frame: Baseline
Present/Absent
Narrow lumbar canal
Time frame: Baseline
Yes/No, Measured on MRI
Postural disorder
Time frame: Baseline
Yes/No
Scoliosis
Time frame: Baseline
Cobb angle
Sagittal balance
Time frame: Baseline
Measured using weight-bearing x-rays
Physical Activity
Time frame: Baseline
International Physical Activity Questionnaire
Exercise Adherence Rating Scale Sleep
Time frame: Baseline
Pittsburgh Questionnaire
Smoking
Time frame: Baseline
Alcohol consumption
Time frame: Baseline
Drug use
Time frame: Baseline
Yes/No
Knowledge about low back pain
Time frame: Baseline
Back Beliefs Questionnaire
Treatment pathway
Time frame: Baseline
Description of previous physiotherapy treatments, infiltrations, osteopathy/manual therapy, medicinal treatments
45 secondary outcomes
Level of disability
Time frame: Month 1
Level of disability
Time frame: Month 3
Level of disability
Time frame: Month 12
Level of pain
Time frame: Month 1
Level of pain
Time frame: Month 3
Level of pain
Time frame: Month 6
Level of pain
Time frame: Month 12
Patient-reported health-related quality of life
Time frame: Baseline
Patient-reported health-related quality of life
Time frame: Month 1
Patient-reported health-related quality of life
Time frame: Month 3
Patient-reported health-related quality of life
Time frame: Month 6
Patient-reported health-related quality of life
Time frame: Month 12
Return to work
Time frame: Month 12
Patients' feelings about symptoms
Time frame: Month 1
Patients' feelings about symptoms
Time frame: Month 3
Patients' feelings about symptoms
Time frame: Month 6
Patients' feelings about symptoms
Time frame: Month 12
Mobility abilities of willing patients recruited in the Nîmes center during walking
Time frame: Baseline
Mobility abilities of willing patients recruited in the Nîmes center during trunk lateral rotations
Time frame: Baseline
Mobility abilities of willing patients recruited in the Nîmes center during drop jumps
Time frame: Baseline
Mobility abilities of willing patients recruited in the Nîmes center during Star Excursion Balance Test
Time frame: Baseline
Mobility abilities of willing patients recruited in the Nîmes center during walking
Time frame: Month 3
Mobility abilities of willing patients recruited in the Nîmes center during trunk lateral rotations
Time frame: Month 3
Mobility abilities of willing patients recruited in the Nîmes center during drop jumps
Time frame: Month 3
Mobility abilities of willing patients recruited in the Nîmes center during Star Excursion Balance Test
Time frame: Month 3
Moderate-to-vigorous physical activity level of willing patients recruited in the Nîmes center over 7 days
Time frame: Baseline
Moderate-to-vigorous physical activity level of willing patients recruited in the Nîmes center over 7 days
Time frame: Month 3
Accelerometric parameters of willing patients recruited in the Nîmes center of walking over 7 days
Time frame: Baseline
Accelerometric parameters of willing patients recruited in the Nîmes center of walking over 7 days
Time frame: Month 3
Number of steps of willing patients recruited in the Nîmes center over 7 days
Time frame: Baseline
Number of steps of willing patients recruited in the Nîmes center over 7 days
Time frame: Month 3
Duration of a walking period of willing patients recruited in the Nîmes center over 7 days
Time frame: Baseline
Duration of a walking period of willing patients recruited in the Nîmes center over 7 days
Time frame: Month 3
Walking speed of willing patients recruited in the Nîmes center
Time frame: Baseline
Walking speed of willing patients recruited in the Nîmes center
Time frame: Month 3
Length of strides of willing patients recruited in the Nîmes center
Time frame: Baseline
Length of strides of willing patients recruited in the Nîmes center
Time frame: Month 3
Duration of strides of willing patients recruited in the Nîmes center
Time frame: Baseline
Duration of strides of willing patients recruited in the Nîmes center
Time frame: Month 3
Frequency of strides
Time frame: Baseline
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 16 Jan 2026.
Related trials for Low Back Pain
Not yet recruiting
Effects of Hip Hinge Exercises on Pain, Range of Motion and Functional Disability in Non-specific Low Back Pain.
Low Back Pain
Not yet recruiting
Effect of Lumbar Stabilization Exercises With and Without YTWL (Scapular Stabilization Exercises) on Reducing Chronic Low Back Pain and Related Disability. A Randomized Clinical Trial,
Chronic Non Specific Mechanical Low Back Pain
Not yet recruiting
Comparing Non-Medicine Strategies for Improving Low Back Pain
Chronic Low-back Pain (cLBP), High-Impact Chronic Pain (HICP)
Not yet recruiting
Effects of Whole-Body Vibration and Cervical Stabilization With Core Stabilization in Young Adults With Non-Specific Low Back Pain
Nonspecific Low Back Pain
Not yet recruiting
Spinery Basivertebral Nerve Ablation for Vertebrogenic Chronic Low Back Pain
Low Back Pain, Chronic Low Back Pain (CLBP)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Arnaud Dupeyron principal investigator
CHU de Nimes
6 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Low Back Pain, run by Centre Hospitalier Universitaire de Nīmes at 6 sites in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 16 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 6 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Arnaud Dupeyron (04.66.68.34.59, arnaud.dupeyron@chu-nimes.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Level of disability (time frame: Baseline). The study lists 39 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Jan 2026.